The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $65.13

Today's change-0.47 -0.72%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $65.13

Today's change-0.47 -0.72%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc down (U.S.)$0.47

Merck & Co Inc closed lower Friday, dropping (U.S.)$0.47 or 0.72% to (U.S.)$65.13. Shares have lost 1.56% over the last five days, but sit 2.50% below their 52-week high. This security has underperformed the S&P 500 by 11.58% during the last year.

Key company metrics

  • Open(U.S.) $65.63
  • Previous close(U.S.) $65.60
  • High(U.S.) $65.70
  • Low(U.S.) $65.07
  • Bid / Ask-- / --
  • YTD % change+10.63%
  • Volume7,465,921
  • Average volume (10-day)8,702,028
  • Average volume (1-month)7,660,842
  • Average volume (3-month)8,204,535
  • 52-week range(U.S.) $58.29 to (U.S.) $66.80
  • Beta0.82
  • Trailing P/E35.47×
  • P/E 1 year forward16.81×
  • Forward PEG2.72×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.89%
  • Trailing EPS(U.S.) $1.84
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue9,9309,43410,11510,536
Total other revenue--------
Total revenue9,9309,43410,11510,536
Gross profit7,7097,3317,6157,935
Total cost of revenue2,2212,1032,5002,601
Total operating expense7,4337,37311,4647,625
Selling / general / administrative2,4362,4102,5642,356
Research & development1,6451,7711,2651,645
Depreciation / amortization779773800772
Interest expense (income), net operating--------
Unusual expense (income)3523164,335251
Other operating expenses, total--------
Operating income2,4972,061-1,3492,911
Interest income (expense), net non-operating-193-182-180-170
Gain (loss) on sale of assets--------
Other--------
Income before tax2,4392,003-1,3562,887
Income after tax1,9511,556-5872,188
Income tax, total488447-769699
Net income1,9461,551-5952,184
Total adjustments to net income--------
Net income before extra. items1,9461,551-5952,184
Minority interest-5-5-8-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9461,551-5952,184
Inc. avail. to common incl. extra. items1,9461,551-5952,184
Diluted net income1,9461,551-5952,184
Dilution adjustment--------
Diluted weighted average shares2,7522,7662,7572,786
Diluted EPS excluding extraordinary itemsvalue per share0.710.56-0.220.78
Dividends per sharevalue per share0.470.470.460.46
Diluted normalized EPSvalue per share1.331.162.421.42